EMGRX Mutual Fund

EMGRX Mutual Fund

NAV$11.91
See how much of EMGRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Sep 30, 2026

Net Assets
$54M
Expense Ratio
1.20%
Dividend Yield (Current)
-
Holdings
87
Inception Date
May 6, 1992
Fund Family
Nuveen
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually
SEC 30-Day Yield
PRO

Performance

YTD+9.07%
1 Year+12.24%
3 Year+17.89%
5 Year+5.22%
10 Year+10.54%

Asset Allocation

Stocks: 97.91%
Bonds: 0.88%
Other: 1.20%
See how much of EMGRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
MMSIMerit Medical Systems Inc1.88%
FCFSFirstcash Inc1.86%
CTRECaretrust Reit Inc Reit Usd.011.83%
HQYHealthequity Inc1.83%
PIImpinj Inc1.69%
Top 10 Concentration: 17.14%Report Date: Sep 30, 2026
Download all 87 holdings for EMGRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$1.89
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

EMGRX Mutual Fund Overview

EMGRX Mutual Fund (Nuveen Small Cap Select Fund Class A) is managed by Nuveen with $53.9M in net assets. EMGRX expense ratio is 1.20%, holding 87 positions across sectors including Health Care, Financials, Information Technology. Inception date: 1992-05-06.

EMGRX performance shows a YTD return of 9.07%. The 1-year return is 12.24% and the 5-year return is 5.22%.

EMGRX top holdings include Merit Medical Systems Inc (1.9%), Firstcash Inc (1.9%), Caretrust Reit Inc Reit Usd.01 (1.8%), Healthequity Inc (1.8%), Impinj Inc (1.7%). Go to all EMGRX holdings, EMGRX sectors, or EMGRX dividends.

EMGRX can be compared against other funds. Use EMGRX overlap to find shared positions, or EMGRX vs another fund for a side-by-side view. EMGRX alternatives are available via the screener, along with tax-loss harvesting opportunities.